157 related articles for article (PubMed ID: 22113125)
1. In brief: icatibant (Firazyr) for hereditary angioedema.
Medical Letter
Med Lett Drugs Ther; 2011 Nov; 53(1378):96. PubMed ID: 22113125
[No Abstract] [Full Text] [Related]
2. Home treatment of hereditary angioedema with icatibant administered by health care professionals.
Farkas H; Csuka D; Zotter Z; Varga L; Böröcz Z; Temesszentandrási G; Jakab L; Karádi I
J Allergy Clin Immunol; 2012 Mar; 129(3):851-852.e2. PubMed ID: 22154383
[No Abstract] [Full Text] [Related]
3. Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
Lumry WR; Li HH; Levy RJ; Potter PC; Farkas H; Moldovan D; Riedl M; Li H; Craig T; Bloom BJ; Reshef A
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):529-37. PubMed ID: 22123383
[TBL] [Abstract][Full Text] [Related]
4. Icatibant in hereditary angioedema: news and challenges.
Bouillet L
Expert Rev Clin Immunol; 2011 May; 7(3):267-72. PubMed ID: 21595592
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Krause K; Metz M; Zuberbier T; Maurer M; Magerl M
J Dtsch Dermatol Ges; 2010 Apr; 8(4):272-4. PubMed ID: 19758369
[TBL] [Abstract][Full Text] [Related]
6. Icatibant for hereditary angioedema.
Gras J
Drugs Today (Barc); 2009 Dec; 45(12):855-64. PubMed ID: 20135020
[TBL] [Abstract][Full Text] [Related]
7. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
Prescrire Int; 2010 Nov; 19(110):245-7. PubMed ID: 21284353
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
Bork K; Frank J; Grundt B; Schlattmann P; Nussberger J; Kreuz W
J Allergy Clin Immunol; 2007 Jun; 119(6):1497-503. PubMed ID: 17418383
[TBL] [Abstract][Full Text] [Related]
9. Management of acute attacks of hereditary angioedema: potential role of icatibant.
Longhurst HJ
Vasc Health Risk Manag; 2010 Sep; 6():795-802. PubMed ID: 20859548
[TBL] [Abstract][Full Text] [Related]
10. Icatibant as acute treatment for hereditary angioedema in adults.
Farkas H
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
[TBL] [Abstract][Full Text] [Related]
11. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
[TBL] [Abstract][Full Text] [Related]
12. Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.
Greve J; Hoffmann TK; Schuler P; Lang S; Chaker A; Bas M
Int J Dermatol; 2011 Oct; 50(10):1294-5. PubMed ID: 21950301
[TBL] [Abstract][Full Text] [Related]
13. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of adult patients with icatibant in hereditary angioedema.
Drake D
Emerg Med J; 2011 Aug; 28(8):720-1. PubMed ID: 21788245
[TBL] [Abstract][Full Text] [Related]
14. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
Baş M; Greve J; Hoffmann TK; Reshef A; Aberer W; Maurer M; Kivity S; Farkas H; Floccard B; Arcoleo F; Martin L; Sitkauskiene B; Bouillet L; Schmid-Grendelmeier P; Li H; Zanichelli A
Allergy; 2013 Nov; 68(11):1452-9. PubMed ID: 24111645
[TBL] [Abstract][Full Text] [Related]
15. Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
Bas M; Bier H; Greve J; Kojda G; Hoffmann TK
Allergy; 2006 Dec; 61(12):1490-2. PubMed ID: 17073887
[No Abstract] [Full Text] [Related]
16. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.
Del Corso I; Puxeddu I; Sardano E; Geraci S; Breggia M; Rocchi V; Migliorini P
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):460-1. PubMed ID: 22626601
[No Abstract] [Full Text] [Related]
17. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
Leimgruber A
Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
[TBL] [Abstract][Full Text] [Related]
18. New Treatments for Hereditary Angioedema.
Johnson NM; Phillips MA
Skin Therapy Lett; 2018 Jan; 23(1):6-8. PubMed ID: 29357215
[TBL] [Abstract][Full Text] [Related]
19. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
Cicardi M; Banerji A; Bracho F; Malbrán A; Rosenkranz B; Riedl M; Bork K; Lumry W; Aberer W; Bier H; Bas M; Greve J; Hoffmann TK; Farkas H; Reshef A; Ritchie B; Yang W; Grabbe J; Kivity S; Kreuz W; Levy RJ; Luger T; Obtulowicz K; Schmid-Grendelmeier P; Bull C; Sitkauskiene B; Smith WB; Toubi E; Werner S; Anné S; Björkander J; Bouillet L; Cillari E; Hurewitz D; Jacobson KW; Katelaris CH; Maurer M; Merk H; Bernstein JA; Feighery C; Floccard B; Gleich G; Hébert J; Kaatz M; Keith P; Kirkpatrick CH; Langton D; Martin L; Pichler C; Resnick D; Wombolt D; Fernández Romero DS; Zanichelli A; Arcoleo F; Knolle J; Kravec I; Dong L; Zimmermann J; Rosen K; Fan WT
N Engl J Med; 2010 Aug; 363(6):532-41. PubMed ID: 20818888
[TBL] [Abstract][Full Text] [Related]
20. Icatibant Exposure During Pregnancy in a Patient With Hereditary Angioedema.
Zanichelli A; Mansi M; Periti G
J Investig Allergol Clin Immunol; 2015; 25(6):447-9. PubMed ID: 26817146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
